Business Standard

Monday, December 23, 2024 | 03:40 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Dr Reddy's posts 33% rise in profit before tax at Rs 766 crore in Q2

The drug major has reported a 26% increase in revenues at Rs 4,801 crore for Q2

reddy, dr reddy's
Premium

Dasarath Reddy Bhuswam Hyderabad
Riding on one-off gains, Dr Reddy’s Laboratories (DRL) has reported a 33 per cent jump in profit before tax (PBT) at Rs 766.4 crore for the September quarter (Q2). Its net profit has more than doubled to Rs 1,092.5 crore.

The drug major has reported a 26 per cent increase in revenues at Rs 4,801 crore for Q2 from Rs 3,797.8 crore in the year-ago period despite a flat growth in the US.

The company’s top line growth was largely hinged on Rs 722.9-crore licence fee received towards the sale of its anti-migraine drug to Upsher-Smith Laboratories and the receipt of Rs

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in